Susquehanna International Group
AZN icon

Susquehanna International Group’s AstraZeneca AZN Stock Holding History

Susquehanna International Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.9M Buy
136,541
+121,634
+816% +$23.5M ﹤0.01% 1872
2025
Q4 		$2.74M Sell
14,907
-31,885
-68% -$5.59M ﹤0.01% 5036
2025
Q3 		$7.18M Buy
46,792
+40,723
+671% +$6.16M ﹤0.01% 3520
2025
Q2 		$848K Sell
6,069
-87,885
-94% -$12.3M ﹤0.01% 7865
2025
Q1 		$13.8M Sell
93,954
-183,667
-66% -$26.6M ﹤0.01% 2137
2024
Q4 		$36.4M Buy
277,621
+224,291
+421% +$31.4M 0.01% 1358
2024
Q3 		$8.31M Sell
53,330
-31,002
-37% -$5M ﹤0.01% 2869
2024
Q2 		$13.2M Buy
84,332
+54,695
+185% +$8.23M ﹤0.01% 2166
2024
Q1 		$4.02M Sell
29,637
-25,476
-46% -$3.37M ﹤0.01% 4006
2023
Q4 		$7.42M Buy
55,113
+36,601
+198% +$4.76M ﹤0.01% 3064
2023
Q3 		$2.51M Sell
18,512
-378,242
-95% -$51.7M ﹤0.01% 4697
2023
Q2 		$56.8M Buy
396,754
+295,608
+292% +$43.5M 0.01% 908
2023
Q1 		$14M Buy
101,146
+44,767
+79% +$6.02M ﹤0.01% 2061
2022
Q4 		$7.64M Sell
56,379
-20,721
-27% -$2.6M ﹤0.01% 2638
2022
Q3 		$8.46M Sell
77,100
-127,368
-62% -$16.2M ﹤0.01% 2402
2022
Q2 		$27M Buy
204,468
+24,858
+14% +$3.26M 0.01% 1218
2022
Q1 		$23.8M Sell
179,610
-245,578
-58% -$29.5M ﹤0.01% 1553
2021
Q4 		$49.5M Sell
425,188
-1,015,311
-70% -$119M 0.01% 1103
2021
Q3 		$173M Buy
1,440,499
+1,206,960
+517% +$140M 0.02% 577
2021
Q2 		$28M Sell
233,539
-342,042
-59% -$37.5M ﹤0.01% 1671
2021
Q1 		$57.2M Sell
575,581
-800,911
-58% -$80.5M 0.01% 1008
2020
Q4 		$138M Buy
1,376,492
+248,213
+22% +$26.3M 0.02% 543
2020
Q3 		$124M Buy
1,128,279
+450,581
+66% +$50.1M 0.02% 494
2020
Q2 		$71.7M Buy
677,698
+598,844
+759% +$61.8M 0.02% 641
2020
Q1 		$7.04M Buy
+78,854
New +$7.42M ﹤0.01% 2143
2019
Q3 		– Sell
-53,477
Closed -$4.64M – 10134
2019
Q2 		$4.42M Buy
53,477
+49,947
+1,415% +$3.92M ﹤0.01% 2882
2019
Q1 		$285K Sell
3,530
-734
-17% -$57.9K ﹤0.01% 7299
2018
Q4 		$324K Sell
4,264
-36,295
-89% -$2.83M ﹤0.01% 6853
2018
Q3 		$3.21M Sell
40,559
-23,931
-37% -$1.81M ﹤0.01% 3267
2018
Q2 		$4.53M Sell
64,490
-84,562
-57% -$6.08M ﹤0.01% 2837
2018
Q1 		$10.4M Buy
149,052
+130,252
+693% +$9.02M ﹤0.01% 1734
2017
Q4 		$1.3M Buy
18,800
+10,787
+135% +$727K ﹤0.01% 4705
2017
Q3 		$543K Buy
8,013
+1,021
+15% +$64.5K ﹤0.01% 6372
2017
Q2 		$477K Sell
6,992
-484,461
-99% -$31.6M ﹤0.01% 6727
2017
Q1 		$30.6M Buy
491,453
+116,540
+31% +$6.78M 0.02% 804
2016
Q4 		$20.5M Buy
+374,913
New +$21.3M 0.01% 1035
2016
Q3 		– Sell
-36,192
Closed -$2.37M – 8376
2016
Q2 		$2.19M Buy
36,192
+12,776
+55% +$742K ﹤0.01% 3417
2016
Q1 		$1.32M Sell
23,416
-76,417
-77% -$4.59M ﹤0.01% 4525
2015
Q4 		$6.78M Sell
99,833
-5,465
-5% -$358K ﹤0.01% 2158
2015
Q3 		$6.7M Buy
105,298
+22,830
+28% +$1.5M ﹤0.01% 2286
2015
Q2 		$5.25M Buy
82,468
+3,343
+4% +$229K ﹤0.01% 2842
2015
Q1 		$5.42M Buy
79,125
+13,232
+20% +$919K ﹤0.01% 2631
2014
Q4 		$4.64M Sell
65,893
-1,167,457
-95% -$83.6M ﹤0.01% 3013
2014
Q3 		$88.1M Buy
1,233,350
+367,007
+42% +$26.9M 0.03% 461
2014
Q2 		$64.4M Buy
866,343
+557,706
+181% +$40.3M 0.03% 569
2014
Q1 		$20M Buy
308,637
+133,037
+76% +$8.59M 0.01% 1274
2013
Q4 		$10.4M Buy
175,600
+137,448
+360% +$7.47M ﹤0.01% 2015
2013
Q3 		$1.98M Buy
+38,152
New +$1.92M ﹤0.01% 4114

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Susquehanna International Group's AZN Position: Q1 2026 in Review

Susquehanna International Group increased its AstraZeneca (AZN) stake by 816% in Q1 2026, buying an estimated $23.5M and bringing the position to 136,541 shares worth $26.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1872.

Susquehanna International Group first reported a position in AZN in Q3 2013 and has held it in 48 quarters since. The position peaked at $173M in Q3 2021. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Susquehanna International Group held 136,541 shares of AstraZeneca worth $26.9M as of Q1 2026.
  • Susquehanna International Group bought 121,634 AstraZeneca shares in Q1 2026, an estimated $23.5M.
  • AstraZeneca made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #1872 holding.
  • Susquehanna International Group first reported a position in AstraZeneca in Q3 2013 and has held it in 48 quarters since.
  • Susquehanna International Group's AstraZeneca position peaked at $173M in Q3 2021.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.